Finance

Beta
Lists
284620:KOSDAQ
Kainos Medicine Inc
₩1,087.00
0.00%
(0.00) 1D
Aug 14, 2:14:45 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 284620...
Mkt. cap
35.97B
Volume
0.00
52-wk high
₩1,490
52-wk low
₩960
EPS
-₩214
Shares outstanding
33.09M
No. of employees
13
Mkt. cap
35.97B
Volume
0.00
52-wk high
₩1,490
52-wk low
₩960
EPS
-₩214
Shares outstanding
33.09M
No. of employees
13
News stories
From sources across the web
About Kainos Medicine Inc
CEO-
Employees13
Founded2007
Headquarters-
SectorBiotechnology
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
176.48M
322.20M
304.09M
370.34M
Cost of goods sold
69.34M
81.11M
766.91M
101.21M
Cost of revenue
69.34M
81.11M
766.91M
101.21M
Research and development expenses
975.80M
-
301.31M
434.57M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-535.54M
1.75B
1.36B
781.13M
Operating expense
1.48B
1.77B
1.81B
1.28B
Total operating expenses
1.55B
1.85B
2.58B
1.38B
Operating income
-1.37B
-1.53B
-2.28B
-1.01B
Other non operating income
-25.01M
108.55K
2.23B
5.01M
EBT including unusual items
-1.92B
-1.84B
-1.85B
-1.31B
EBT excluding unusual items
-1.91B
-1.84B
-626.59M
-1.31B
Income tax expense
1.14M
-12.12K
1.15M
-
Effective tax rate
-0.06%
-
-0.06%
-
Other operating expenses
144.24M
-
50.51M
64.69M
Net income
-1.92B
-1.84B
-1.86B
-1.31B
Net profit margin
-1,086.37%
-572.22%
-610.39%
-353.28%
Earnings per share
-
-
-
-
Interest and investment income
39.99M
31.77M
24.76M
19.24M
Interest expense
-7.84M
-6.18M
-4.60M
-2.68M
Net interest expenses
32.15M
25.59M
20.16M
16.56M
Depreciation and amortization charges
316.77M
-
66.69M
-
EBITDA
-1.28B
-1.39B
-2.15B
-1.01B
Gain or loss from assets sale
34.27M
-29.00K
18.24M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more